Molly E. Martin, Ph.D.
Affiliations: | 2007 | University of Iowa, Iowa City, IA |
Area:
non-viral gene delivery systemsGoogle:
"Molly Martin"Mean distance: 9.9 | S | N | B | C | P |
Parents
Sign in to add mentor| Kevin G. Rice | grad student | 2007 | University of Iowa | |
| (Design and testing of novel intrinsic proteasome inhibitory gene transfer peptides.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Martin ME, Sue O'Dorisio M, Leverich WM, et al. (2013) "Click"-cyclized (68)Ga-labeled peptides for molecular imaging and therapy: synthesis and preliminary in vitro and in vivo evaluation in a melanoma model system. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 194: 149-75 |
| Baumhover NJ, Martin ME, Parameswarappa SG, et al. (2011) Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry. Bioorganic & Medicinal Chemistry Letters. 21: 5757-61 |
| Martin ME, Parameswarappa SG, O'Dorisio MS, et al. (2010) A DOTA-peptide conjugate by copper-free click chemistry. Bioorganic & Medicinal Chemistry Letters. 20: 4805-7 |
| Martin ME, Rice KG. (2008) A novel class of intrinsic proteasome inhibitory gene transfer peptides. Bioconjugate Chemistry. 19: 370-6 |
| Martin ME, Rice KG. (2007) Peptide-guided gene delivery. The Aaps Journal. 9: E18-29 |
| Chen CP, Kim JS, Liu D, et al. (2007) Synthetic PEGylated glycoproteins and their utility in gene delivery. Bioconjugate Chemistry. 18: 371-8 |
| Martin ME, Kim J, Rice KG. (2006) 168. Peptide Aldehyde Inhibitors of the Proteasome as Improved Gene Transfer Agents Molecular Therapy. 13: S65 |
| McAnuff M, Rettig G, Kim J, et al. (2006) 1037. Formulating and Testing of Targeted siRNA for Applications In Vivo Molecular Therapy. 13: S397-S398 |
| Liu D, Martin ME, Chen C, et al. (2004) 833. Metabolically Stabilized Non-Viral Gene Delivery Systems Molecular Therapy. 9 |
| Milne TA, Briggs SD, Brock HW, et al. (2002) MLL targets SET domain methyltransferase activity to Hox gene promoters. Molecular Cell. 10: 1107-17 |